SkinHealth Systems Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price
SKIN sits 19% above its 52-week low of $0.551.
Summary
SkinHealth Systems Inc. received a Nasdaq delisting notice for failing to maintain a minimum $1.00 bid price, initiating a 180-day compliance period to avoid potential delisting.
Key Events · Legal and Risk Events · SKIN
-
Nasdaq Delisting Notice Received
On May 8, 2026, SkinHealth Systems Inc. received a notification from Nasdaq for non-compliance with the minimum $1.00 bid price requirement (Rule 5550(a)(2)).
-
Non-Compliance Period
The company's Class A Common Stock traded below $1.00 per share for 30 consecutive business days from March 26, 2026, through May 7, 2026.
-
Compliance Deadline
SkinHealth Systems has 180 calendar days, until November 4, 2026, to regain compliance by having its closing bid price be $1.00 or more for at least ten consecutive business days.
-
Potential for Extension or Delisting
If compliance is not met, the company may be eligible for an additional 180-day period, potentially requiring a reverse stock split. Failure to comply could lead to delisting.
Analysis · SKIN · Industrial Applications And Services
SkinHealth Systems Inc. received a formal notification from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement. This is a critical event as failure to regain compliance by November 4, 2026, could lead to delisting from The Nasdaq Capital Market. While there is no immediate impact on trading, the company will need to take action, potentially including a reverse stock split, to boost its share price above the $1.00 threshold for at least ten consecutive business days. Delisting can severely impact liquidity and institutional investor interest.
At the time of this filing, SKIN was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $84.8M. The 52-week trading range was $0.55 to $2.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.